Brinzolamide and timolol optionally in the form of pharmaceutically acceptable salts such as the combination of the product brinzolamide / timolol maleate (AZARGA)

摘要

Ophthalmic suspensions containing brinzolamide or brinzolamide and a beta-blocker and processes for manufacturing the suspensions are disclosed.